Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 323

1.

Gastric mucormycosis complicated by a gastropleural fistula: A case report and review of the literature.

Uchida T, Okamoto M, Fujikawa K, Yoshikawa D, Mizokami A, Mihara T, Kondo A, Ohba K, Kurohama K, Nakashima M, Sekine I, Nakamura S, Miyazaki Y, Kawakami A.

Medicine (Baltimore). 2019 Nov;98(48):e18142. doi: 10.1097/MD.0000000000018142.

2.

Factors Associated With Treatment Satisfaction After Robot-assisted Radical Prostatectomy.

Nakagawa T, Kadono Y, Naito R, Iwamoto H, Yaegashi H, Iijima M, Kawaguchi S, Nohara T, Shigehara K, Izumi K, Mizokami A.

Anticancer Res. 2019 Nov;39(11):6339-6346. doi: 10.21873/anticanres.13845.

PMID:
31704865
3.

GLP-1 signaling is required for improvement of glucose tolerance by osteocalcin.

Mizokami A, Mukai S, Gao J, Kawakubo-Yasukochi T, Otani T, Takeuchi H, Jimi E, Hirata M.

J Endocrinol. 2019 Nov 1. pii: JOE-19-0288.R1. doi: 10.1530/JOE-19-0288. [Epub ahead of print]

PMID:
31693486
4.

Diagnostic efficacy of ultrasound detection of enthesitis in peripheral spondyloarthritis.

Fujikawa K, Kawashiri SY, Endo Y, Mizokami A, Tsukada T, Mine M, Uetani M, Kawakami A.

Mod Rheumatol. 2019 Nov 14:1-7. doi: 10.1080/14397595.2019.1687113. [Epub ahead of print]

PMID:
31663417
5.

Serial analysis of cytokine and chemokine profiles and viral load in severe fever with thrombocytopenia syndrome: Case report and review of literature.

Fujikawa K, Koga T, Honda T, Uchida T, Okamoto M, Endo Y, Mihara T, Kondo A, Shimada S, Hayasaka D, Morita K, Mizokami A, Kawakami A.

Medicine (Baltimore). 2019 Oct;98(42):e17571. doi: 10.1097/MD.0000000000017571. Review.

6.

Y chromosome microdeletion screening using a new molecular diagnostic method in 1030 Japanese males with infertility.

Iijima M, Shigehara K, Igarashi H, Kyono K, Suzuki Y, Tsuji Y, Kobori Y, Kobayashi H, Mizokami A.

Asian J Androl. 2019 Oct 11. doi: 10.4103/aja.aja_97_19. [Epub ahead of print]

7.

Phospholipase C-related catalytically inactive protein regulates lipopolysaccharide-induced hypothalamic inflammation-mediated anorexia in mice.

Yamawaki Y, Shirawachi S, Mizokami A, Nozaki K, Ito H, Asano S, Oue K, Aizawa H, Yamawaki S, Hirata M, Kanematsu T.

Neurochem Int. 2019 Dec;131:104563. doi: 10.1016/j.neuint.2019.104563. Epub 2019 Oct 4.

8.

Intraoperative hypotension caused by oral administration of 5-aminolevulinic acid for photodynamic diagnosis in patients with bladder cancer.

Nohara T, Kato Y, Nakano T, Nakagawa T, Iwamoto H, Yaegashi H, Nakashima K, Iijima M, Kawaguchi S, Shigehara K, Izumi K, Kadono Y, Mizokami A.

Int J Urol. 2019 Nov;26(11):1064-1068. doi: 10.1111/iju.14099. Epub 2019 Sep 11.

PMID:
31512303
9.

Considering bone health in the treatment of prostate cancer bone metastasis based on the results of the ERA-223 trial.

Mizokami A, Kimura G, Fujii Y, Hinotsu S, Izumi K.

Int J Clin Oncol. 2019 Dec;24(12):1629-1631. doi: 10.1007/s10147-019-01518-7. Epub 2019 Sep 3. No abstract available.

PMID:
31482239
10.

Phase I trial of TAK-385 in hormone treatment-naïve Japanese patients with nonmetastatic prostate cancer.

Suzuki H, Uemura H, Mizokami A, Hayashi N, Miyoshi Y, Nagamori S, Enomoto Y, Akaza H, Asato T, Kitagawa T, Suzuki K.

Cancer Med. 2019 Oct;8(13):5891-5902. doi: 10.1002/cam4.2442. Epub 2019 Aug 19.

11.

Efficacy and safety of cytokines versus first-line sunitinib and second-line axitinib for patients with metastatic renal cell carcinoma (ESCAPE study): A study protocol for phase III randomized sequential open-label study.

Kadono Y, Konaka H, Izumi K, Anai S, Fujimoto K, Ishibashi K, Kawai N, Kato T, Iba A, Masumori N, Yoshimura K, Mizokami A.

Contemp Clin Trials Commun. 2019 Jun 26;15:100403. doi: 10.1016/j.conctc.2019.100403. eCollection 2019 Sep.

12.

Rheumatoid Arthritis Complicated with Nasal Septum Perforation Due to Methotrexate-associated Lymphoproliferative Disorder.

Sakaguchi R, Fujikawa K, Okamoto M, Matsuo E, Matsumoto K, Uchida T, Shin-Ya K, Nakashima M, Mizokami A, Kawakami A.

Intern Med. 2019 Nov 1;58(21):3167-3171. doi: 10.2169/internalmedicine.2995-19. Epub 2019 Jul 10.

13.

Metastatic urachal cancer treated effectively with gemcitabine/cisplatin combination chemotherapy and radiotherapy: A case report.

Yaegashi H, Kadomoto S, Naito R, Makino T, Iwamoto H, Nohara T, Shigehara K, Izumi K, Kadono Y, Mizokami A.

Mol Clin Oncol. 2019 Aug;11(2):139-142. doi: 10.3892/mco.2019.1865. Epub 2019 May 22.

14.

A case of mesh erosion in the ureter eight years after a tension-free vaginal mesh surgery.

Nakagawa T, Kawaguchi S, Mizokami A.

Int Urogynecol J. 2019 Dec;30(12):2199-2200. doi: 10.1007/s00192-019-04028-2. Epub 2019 Jun 26. No abstract available.

PMID:
31243499
15.

Reiter's syndrome following intravesical Bacillus Calmette-Guerin therapy for bladder carcinoma: a report of five cases.

Nakagawa T, Shigehara K, Naito R, Yaegashi H, Nakashima K, Iijima M, Kawaguchi S, Nohara T, Kitagawa Y, Izumi K, Kadono Y, Mizokami A.

Int Cancer Conf J. 2018 Aug 21;7(4):148-151. doi: 10.1007/s13691-018-0342-1. eCollection 2018 Oct.

16.

Phospholipase C-related catalytically inactive protein: A novel signaling molecule for modulating fat metabolism and energy expenditure.

Kanematsu T, Oue K, Okumura T, Harada K, Yamawaki Y, Asano S, Mizokami A, Irifune M, Hirata M.

J Oral Biosci. 2019 Jun;61(2):65-72. doi: 10.1016/j.job.2019.04.002. Epub 2019 May 15. Review.

PMID:
31109860
17.

Initial Experience With Radium-223 Chloride Treatment at the Kanazawa University Hospital.

Nakashima K, Makino T, Kadomoto S, Iwamoto H, Yaegashi H, Iijima M, Kawaguchi S, Nohara T, Shigehara K, Izumi K, Kadono Y, Matsuo S, Mizokami A.

Anticancer Res. 2019 May;39(5):2607-2614. doi: 10.21873/anticanres.13384.

PMID:
31092459
18.

Quantification of Bone Metastasis of Castration-resistant Prostate Cancer After Enzalutamide and Abiraterone Acetate Using Bone Scan Index on Bone Scintigraphy.

Kadomoto S, Yaegashi H, Nakashima K, Iijima M, Kawaguchi S, Nohara T, Shigehara K, Izumi K, Kadono Y, Nakajima K, Mizokami A.

Anticancer Res. 2019 May;39(5):2553-2559. doi: 10.21873/anticanres.13377.

PMID:
31092452
19.

Testosterone Replacement Therapy for Patients with Hypogonadism after High Dose-Rate Brachytherapy for High-Risk Prostate Cancer: A Report of Six Cases and Literature Review.

Kadomoto S, Shigehara K, Iwamoto H, Yaegashi H, Izumi K, Kadono Y, Mizokami A.

World J Mens Health. 2019 May 2. doi: 10.5534/wjmh.180130. [Epub ahead of print]

20.

Effectiveness of Synthetic Polymer-coated Peripherally Inserted Central Catheter in Patients With Advanced Cancer.

Takezawa Y, Izumi K, Kamijima T, Machioka K, Shima T, Iwamoto H, Nohara T, Shigehara K, Kadono Y, Seto C, Mizokami A.

In Vivo. 2019 May-Jun;33(3):877-880. doi: 10.21873/invivo.11553.

21.

Combination of ultrasound power Doppler-verified synovitis and seropositivity accurately identifies patients with early-stage rheumatoid arthritis.

Kawashiri SY, Fujikawa K, Nishino A, Takatani A, Shimizu T, Umeda M, Fukui S, Igawa T, Koga T, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Mizokami A, Maeda T, Kawakami A.

Int J Rheum Dis. 2019 May;22(5):842-851. doi: 10.1111/1756-185X.13543. Epub 2019 Mar 18.

PMID:
30883001
22.

Three-year follow-up of a phase II study of radium-223 dichloride in Japanese patients with symptomatic castration-resistant prostate cancer and bone metastases.

Uemura H, Uemura H, Nagamori S, Wakumoto Y, Kimura G, Kikukawa H, Yokomizo A, Mizokami A, Kosaka T, Masumori N, Kawasaki Y, Yonese J, Nasu Y, Fukasawa S, Sugiyama T, Kinuya S, Hosono M, Yamaguchi I, Akagawa T, Matsubara N.

Int J Clin Oncol. 2019 May;24(5):557-566. doi: 10.1007/s10147-018-01389-4. Epub 2019 Mar 14.

23.

Suppressive Role of Androgen/Androgen Receptor Signaling via Chemokines on Prostate Cancer Cells.

Izumi K, Mizokami A.

J Clin Med. 2019 Mar 13;8(3). pii: E354. doi: 10.3390/jcm8030354. Review.

24.

Gonadal function and testicular histology in males with Prader-Willi syndrome.

Matsuyama S, Matsui F, Matsuoka K, Iijima M, Takeuchi M, Ida S, Matsumoto F, Mizokami A.

Endocrinol Diabetes Metab. 2018 Oct 30;2(1):e00049. doi: 10.1002/edm2.49. eCollection 2019 Jan.

25.

Palonosetron on Days 1 and 5 Versus Granisetron Daily (Days 1-5) in Germ Cell Tumour Therapy.

Shimura Y, Izumi K, Itai S, Iwamoto H, Yaegashi H, Suga Y, Shimada T, Mizokami A, Sai Y.

In Vivo. 2019 Mar-Apr;33(2):643-647. doi: 10.21873/invivo.11522.

26.

A Case Report of Chyloretroperitoneum Post Living-Donor Transplantation.

Kawaguchi S, Kadono Y, Nohara T, Kato Y, Nakagawa T, Urata S, Yaegashi H, Nakashima K, Iijima M, Shigehara K, Izumi K, Mizokami A.

Urol Int. 2019 Feb 20:1-3. doi: 10.1159/000497108. [Epub ahead of print]

PMID:
30799423
27.

Novel Prevention Procedure for Inguinal Hernia after Robot-Assisted Radical Prostatectomy: Results from a Prospective Randomized Trial.

Kadono Y, Nohara T, Kawaguchi S, Sakamoto J, Iwamoto H, Yaegashi H, Nakashima K, Iijima M, Shigehara K, Izumi K, Mizokami A.

J Endourol. 2019 Apr;33(4):302-308. doi: 10.1089/end.2018.0898. Epub 2019 Mar 20.

PMID:
30767563
28.

Characteristics of late-onset spondyloarthritis in Japan: A retrospective cohort study.

Endo Y, Fujikawa K, Koga T, Mizokami A, Mine M, Tsukada T, Uetani M, Kawakami A.

Medicine (Baltimore). 2019 Feb;98(7):e14431. doi: 10.1097/MD.0000000000014431.

29.

Efficacy of combined prophylactic use of levofloxacin and isepamicin for transrectal prostate needle biopsy: A retrospective single-center study.

Nakagawa R, Shigehara K, Aoyama S, Urata S, Ofude M, Miyagi T, Nakashima T, Izumi K, Mizokami A.

J Infect Chemother. 2019 May;25(5):337-340. doi: 10.1016/j.jiac.2019.01.004. Epub 2019 Feb 2.

PMID:
30718193
30.

The five-year effects of testosterone replacement therapy on lipid profile and glucose tolerance among hypogonadal men in Japan: a case control study.

Kato Y, Shigehara K, Nakashima K, Iijima M, Kawagushi S, Nohara T, Izumi K, Kadono Y, Konaka H, Namiki M, Mizokami A.

Aging Male. 2019 Jan 16:1-6. doi: 10.1080/13685538.2018.1550060. [Epub ahead of print]

PMID:
30651019
31.

Health-related Quality of Life and Toxicity After Single-fraction High-dose-rate Brachytherapy With External Beam Radiotherapy for Localized and Locally Advanced Prostate Cancer.

Makino T, Nakashima K, Iijima M, Kawaguchi S, Nohara T, Shigehara K, Izumi K, Kadono Y, Kumano T, Mizokami A.

Anticancer Res. 2019 Jan;39(1):477-486. doi: 10.21873/anticanres.13137.

PMID:
30591498
32.

High Serum CA19-9 Concentration Indicates High Chemosensitivity and Better Survival in Advanced Urothelial Carcinoma.

Yaegashi H, Izumi K, Kadomoto S, Naito R, Makino T, Iwamoto H, Nohara T, Shigehara K, Kadono Y, Mizokami A.

Anticancer Res. 2019 Jan;39(1):375-380. doi: 10.21873/anticanres.13122.

PMID:
30591483
33.

Gemcitabine Plus Cisplatin Split Versus Gemcitabine Plus Carboplatin for Advanced Urothelial Cancer With Cisplatin-unfit Renal Function.

Izumi K, Iwamoto H, Yaegashi H, Shigehara K, Nohara T, Kadono Y, Mizokami A.

In Vivo. 2019 Jan-Feb;33(1):167-172. doi: 10.21873/invivo.11454.

34.

Evaluating urinary incontinence before and after radical prostatectomy using the international consultation on incontinence questionnaire-short form.

Machioka K, Kadono Y, Naito R, Nakashima K, Iijima M, Kawaguchi S, Shigehara K, Nohara T, Izumi K, Mizokami A.

Neurourol Urodyn. 2019 Feb;38(2):726-733. doi: 10.1002/nau.23907. Epub 2018 Dec 21.

PMID:
30576037
35.

Coffee diterpenes kahweol acetate and cafestol synergistically inhibit the proliferation and migration of prostate cancer cells.

Iwamoto H, Izumi K, Natsagdorj A, Naito R, Makino T, Kadomoto S, Hiratsuka K, Shigehara K, Kadono Y, Narimoto K, Saito Y, Nakagawa-Goto K, Mizokami A.

Prostate. 2019 Apr;79(5):468-479. doi: 10.1002/pros.23753. Epub 2018 Dec 19.

PMID:
30569541
36.

Osteocalcin triggers Fas/FasL-mediated necroptosis in adipocytes via activation of p300.

Otani T, Matsuda M, Mizokami A, Kitagawa N, Takeuchi H, Jimi E, Inai T, Hirata M.

Cell Death Dis. 2018 Dec 13;9(12):1194. doi: 10.1038/s41419-018-1257-7.

37.

Prognosis of patients with prostate cancer and middle range prostate - specific antigen levels of 20 - 100 ng / mL.

Iwamoto H, Izumi K, Kadono Y, Mizokami A.

Int Braz J Urol. 2019 Jan-Feb;45(1):61-67. doi: 10.1590/S1677-5538.IBJU.2018.0143.

38.

CCL2 induces resistance to the antiproliferative effect of cabazitaxel in prostate cancer cells.

Natsagdorj A, Izumi K, Hiratsuka K, Machioka K, Iwamoto H, Naito R, Makino T, Kadomoto S, Shigehara K, Kadono Y, Lin WJ, Maolake A, Mizokami A.

Cancer Sci. 2019 Jan;110(1):279-288. doi: 10.1111/cas.13876. Epub 2018 Dec 7.

39.

Etiological role of human papillomavirus infection in the development of penile cancer.

Sakamoto J, Shigehara K, Nakashima K, Kawaguchi S, Nakashima T, Shimamura M, Yasuda M, Kato T, Hasegawa T, Kobori Y, Okada H, Deguchi T, Izumi K, Kadono Y, Mizokami A.

Int J Infect Dis. 2019 Jan;78:148-154. doi: 10.1016/j.ijid.2018.11.003. Epub 2018 Nov 10.

40.

Predictors of persistent stress urinary incontinence after transvaginal mesh repair.

Kawaguchi S, Narimoto K, Urata S, Takeyama M, Kadono Y, Mizokami A.

BMC Womens Health. 2018 Oct 25;18(1):174. doi: 10.1186/s12905-018-0667-0.

41.

5'-Chloro-2,2'-dihydroxychalcone and related flavanoids as treatments for prostate cancer.

Saito Y, Mizokami A, Tsurimoto H, Izumi K, Goto M, Nakagawa-Goto K.

Eur J Med Chem. 2018 Sep 5;157:1143-1152. doi: 10.1016/j.ejmech.2018.08.069. Epub 2018 Aug 28.

PMID:
30189396
42.

Effect of testosterone replacement therapy on sexual function and glycemic control among hypogonadal men with type 2 diabetes mellitus.

Shigehara K, Konaka H, Kato Y, Iijima M, Nakashima K, Kawaguchi S, Nohara T, Izumi K, Namiki M, Mizokami A.

Int J Impot Res. 2019 Jan;31(1):25-30. doi: 10.1038/s41443-018-0065-z. Epub 2018 Aug 22.

PMID:
30135606
43.

Changes in penile length after radical prostatectomy: effect of neoadjuvant androgen deprivation therapy.

Kadono Y, Nohara T, Kawaguchi S, Sakamoto J, Makino T, Nakashima K, Iijima M, Shigehara K, Izumi K, Mizokami A.

Andrology. 2018 Nov;6(6):903-908. doi: 10.1111/andr.12517. Epub 2018 Jul 2.

44.

Effectiveness and Safety of Pegfilgrastim in BEP Treatment for Patients with Germ Cell Tumor.

Iwamoto H, Izumi K, Natsagdorj A, Makino T, Nohara T, Shigehara K, Kadono Y, Mizokami A.

In Vivo. 2018 Jul-Aug;32(4):899-903. doi: 10.21873/invivo.11326.

45.

Imaging Somatostatin Receptor Activity in Neuroendocrine-differentiated Prostate Cancer.

Mori H, Nakajima K, Kadomoto S, Mizokami A, Ikeda H, Wakabayashi H, Kinuya S.

Intern Med. 2018 Nov 1;57(21):3123-3128. doi: 10.2169/internalmedicine.0630-17. Epub 2018 Jun 6.

46.

Risk factors for human papillomavirus detection in urine samples of heterosexual men visiting urological clinics in Japan.

Nakashima K, Shigehara K, Kitamura T, Yaegashi H, Shimamura M, Kawaguchi S, Izumi K, Kadono Y, Mizokami A.

J Infect Chemother. 2018 Sep;24(9):713-717. doi: 10.1016/j.jiac.2018.04.011. Epub 2018 May 11.

PMID:
29759898
47.

Interleukin-6 induces VEGF secretion from prostate cancer cells in a manner independent of androgen receptor activation.

Ishii K, Sasaki T, Iguchi K, Kajiwara S, Kato M, Kanda H, Hirokawa Y, Arima K, Mizokami A, Sugimura Y.

Prostate. 2018 Aug;78(11):849-856. doi: 10.1002/pros.23643. Epub 2018 Apr 29.

PMID:
29707793
48.

Establishment and characterization of two cabazitaxel-resistant prostate cancer cell lines.

Machioka K, Izumi K, Kadono Y, Iwamoto H, Naito R, Makino T, Kadomoto S, Natsagdorj A, Keller ET, Zhang J, Mizokami A.

Oncotarget. 2018 Mar 5;9(22):16185-16196. doi: 10.18632/oncotarget.24609. eCollection 2018 Mar 23.

49.

Prediction of organ involvement in systemic sclerosis by serum biomarkers and peripheral endothelial function.

Kawashiri SY, Nishino A, Igawa T, Takatani A, Shimizu T, Umeda M, Fukui S, Okada A, Suzuki T, Koga T, Iwamoto N, Ichinose K, Tamai M, Nakashima M, Mizokami A, Matsuoka N, Migita K, Ogawa F, Ikeda S, Maemura K, Nakamura H, Origuchi T, Maeda T, Kawakami A.

Clin Exp Rheumatol. 2018 Jul-Aug;36 Suppl 113(4):102-108. Epub 2018 Apr 12.

50.

Role of bone scan index in the prognosis and effects of therapy on prostate cancer with bone metastasis: Study design and rationale for the multicenter Prostatic Cancer Registry of Standard Hormonal and Chemotherapy Using Bone Scan Index (PROSTAT-BSI) study.

Nakajima K, Kaneko G, Takahashi S, Matsuyama H, Shiina H, Ichikawa T, Horikoshi H, Hashine K, Sugiyama Y, Miyao T, Kamiyama M, Harada K, Ito A, Mizokami A; PROSTAT-BSI Investigators.

Int J Urol. 2018 May;25(5):492-499. doi: 10.1111/iju.13556. Epub 2018 Apr 6.

Supplemental Content

Loading ...
Support Center